Almirall SA (LBTSF)
15.35
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Almirall Total Assets (Quarterly) : 2.685B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.685B |
| March 31, 2016 | 3.050B |
| December 31, 2015 | 2.751B |
| September 30, 2015 | 2.783B |
| June 30, 2015 | 2.784B |
| March 31, 2015 | 2.751B |
| December 31, 2014 | 3.074B |
| September 30, 2014 | 2.281B |
| June 30, 2014 | 2.464B |
| March 31, 2014 | 2.464B |
| December 31, 2013 | 2.443B |
| September 30, 2013 | 1.814B |
| June 30, 2013 | 1.732B |
| March 31, 2013 | 1.710B |
| December 31, 2012 | 1.788B |
| September 30, 2012 | 1.805B |
| June 30, 2012 | 1.740B |
| March 31, 2012 | 1.924B |
| December 31, 2011 | 1.891B |
| September 30, 2011 | 2.045B |
| Date | Value |
|---|---|
| June 30, 2011 | 2.237B |
| March 31, 2011 | 2.170B |
| December 31, 2010 | 2.062B |
| September 30, 2010 | 2.051B |
| June 30, 2010 | 1.789B |
| March 31, 2010 | 1.995B |
| December 31, 2009 | 2.128B |
| September 30, 2009 | 2.082B |
| June 30, 2009 | 2.004B |
| March 31, 2009 | 1.920B |
| December 31, 2008 | 1.941B |
| September 30, 2008 | 1.950B |
| June 30, 2008 | 2.147B |
| March 31, 2008 | 2.270B |
| December 31, 2007 | 2.104B |
| September 30, 2007 | |
| June 30, 2007 | 1.427B |
| March 31, 2007 | 1.221B |
| December 31, 2006 | 1.469B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 1.067B |
| Eli Lilly & Co. | 116.58B |
| AstraZeneca PLC | 114.02B |
| ANI Pharmaceuticals, Inc. | 1.422B |
| Corcept Therapeutics, Inc. | 814.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 947.80M |
| Shareholders Equity (Quarterly) | 1.737B |